Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
YSB Inc. ( (HK:9885) ) just unveiled an update.
YSB Inc. has entered into a strategic cooperation and business deployment agreement with Shenzhen DOBOT Corp Ltd to explore the application of collaborative robots (cobots) and AI products in pharmaceutical R&D, warehousing, and medication services. This partnership aims to integrate robotics with the pharmaceutical industry, enhancing technology development and societal health. The initial phase involves deploying cobots in pharmacies and warehousing, with DOBOT producing the robots and YSB Inc. handling sales within the pharmaceutical sector. This collaboration is expected to drive innovation and resource integration, leveraging the strengths of both companies.
More about YSB Inc.
YSB Inc., founded in 2015, operates in the pharmaceutical industry, focusing on the outside-of-hospital pharmaceutical market and primary healthcare sector. The company provides digital and intelligent solutions to pharmacies and healthcare institutions, aiming to empower enterprises across the pharmaceutical industry’s supply chain.
Average Trading Volume: 6,450,260
Technical Sentiment Signal: Hold
For an in-depth examination of 9885 stock, go to TipRanks’ Stock Analysis page.